117 related articles for article (PubMed ID: 21923652)
41. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.
Winter SS; Holdsworth MT; Devidas M; Raisch DW; Chauvenet A; Ravindranath Y; Ducore JM; Amylon MD
Pediatr Blood Cancer; 2006 Feb; 46(2):179-86. PubMed ID: 16007607
[TBL] [Abstract][Full Text] [Related]
42. Treatment of childhood acute lymphoblastic leukaemia with the BFM regimen.
Kudva GC; Chandy M; Raghupathy P; Dennison D; Srivastava A; Bhushan V; Singh R
Indian J Cancer; 1994 Jun; 31(2):78-85. PubMed ID: 7927453
[TBL] [Abstract][Full Text] [Related]
43. Estimating late adverse events using competing risks after autologous stem-cell transplantation in aggressive non-Hodgkin lymphoma patients.
Ruiz-Soto R; Sergent G; Gisselbrecht C; Larghero J; Ertault M; Hennequin C; Manson J; de Kerviler E; Briere J; Mounier N
Cancer; 2005 Dec; 104(12):2735-42. PubMed ID: 16284986
[TBL] [Abstract][Full Text] [Related]
44. [Results of treatment in non-Hodgkin's lymphoma in children using the YU-77, YU-84 and YU-87 protocols].
Vilibić T; Konja J
Lijec Vjesn; 1992; 114(1-4):57-61. PubMed ID: 1343029
[TBL] [Abstract][Full Text] [Related]
45. Therapy-associated genetic aberrations in patients treated for non-Hodgkin lymphoma.
Basecke J; Podleschny M; Becker A; Seiffert E; Schwiers I; Schwiers R; Haase D; Glass B; Schmitz N; Trumper L; Griesinger F
Br J Haematol; 2008 Apr; 141(1):52-9. PubMed ID: 18324966
[TBL] [Abstract][Full Text] [Related]
46. Nijmegen Breakage Syndrome: Clinical and Immunological Features, Long-Term Outcome and Treatment Options - a Retrospective Analysis.
Wolska-Kuśnierz B; Gregorek H; Chrzanowska K; Piątosa B; Pietrucha B; Heropolitańska-Pliszka E; Pac M; Klaudel-Dreszler M; Kostyuchenko L; Pasic S; Marodi L; Belohradsky BH; Čižnár P; Shcherbina A; Kilic SS; Baumann U; Seidel MG; Gennery AR; Syczewska M; Mikołuć B; Kałwak K; Styczyński J; Pieczonka A; Drabko K; Wakulińska A; Gathmann B; Albert MH; Skarżyńska U; Bernatowska E;
J Clin Immunol; 2015 Aug; 35(6):538-49. PubMed ID: 26271390
[TBL] [Abstract][Full Text] [Related]
47. Non-Hodgkin lymphoma in children and adolescents.
Reiter A
Klin Padiatr; 2013 May; 225 Suppl 1():S87-93. PubMed ID: 23700066
[TBL] [Abstract][Full Text] [Related]
48. Geographical Distribution, Incidence, Malignancies, and Outcome of 136 Eastern Slavic Patients With Nijmegen Breakage Syndrome and
Sharapova SO; Pashchenko OE; Bondarenko AV; Vakhlyarskaya SS; Prokofjeva T; Fedorova AS; Savchak I; Mareika Y; Valiev TT; Popa A; Tuzankina IA; Vlasova EV; Sakovich IS; Polyakova EA; Rumiantseva NV; Naumchik IV; Kulyova SA; Aleshkevich SN; Golovataya EI; Minakovskaya NV; Belevtsev MV; Latysheva EA; Latysheva TV; Beznoshchenko AG; Akopyan H; Makukh H; Kozlova O; Varabyou DS; Ballow M; Ong MS; Walter JE; Kondratenko IV; Kostyuchenko LV; Aleinikova OV
Front Immunol; 2020; 11():602482. PubMed ID: 33488600
[TBL] [Abstract][Full Text] [Related]
49. [Neurotoxic the effects of chemotherapy on the function of the central nervous system in children with lymphoid tumors].
Kuznetsova EI
Patol Fiziol Eksp Ter; 2014; (4):71-7. PubMed ID: 25980230
[TBL] [Abstract][Full Text] [Related]
50. Diagnostic and therapeutic approach to children with Nijmegen breakage syndrome in relation to development of lymphoid malignancies.
Filipiuk A; Kozakiewicz A; Kośmider K; Lejman M; Zawitkowska J
Ann Agric Environ Med; 2022 Jun; 29(2):207-214. PubMed ID: 35767752
[TBL] [Abstract][Full Text] [Related]
51. Non-Hodgkin lymphoma and pre-existing conditions: spectrum, clinical characteristics and outcome in 213 children and adolescents.
Attarbaschi A; Carraro E; Abla O; Barzilai-Birenboim S; Bomken S; Brugieres L; Bubanska E; Burkhardt B; Chiang AK; Csoka M; Fedorova A; Jazbec J; Kabickova E; Krenova Z; Lazic J; Loeffen J; Mann G; Niggli F; Miakova N; Osumi T; Ronceray L; Uyttebroeck A; Williams D; Woessmann W; Wrobel G; Pillon M;
Haematologica; 2016 Dec; 101(12):1581-1591. PubMed ID: 27515251
[TBL] [Abstract][Full Text] [Related]
52. A rare case of primary gastric Hodgkin lymphoma in an adolescent with Nijmegen breakage syndrome.
Batiuk E; Bassett M; Hakar M; Lin HC; Hunter AK
BMC Pediatr; 2023 Apr; 23(1):189. PubMed ID: 37085783
[TBL] [Abstract][Full Text] [Related]
53. Nijmegen breakage syndrome: case report and review of literature.
Hasbaoui BE; Elyajouri A; Abilkassem R; Agadr A
Pan Afr Med J; 2020; 35():85. PubMed ID: 32537088
[TBL] [Abstract][Full Text] [Related]
54. T-lymphoblastic leukemia/lymphoma in macedonian patients with Nijmegen breakage syndrome.
Kocheva SA; Martinova K; Antevska-Trajkova Z; Coneska-Jovanova B; Eftimov A; Dimovski AJ
Balkan J Med Genet; 2016 Jul; 19(1):91-94. PubMed ID: 27785413
[TBL] [Abstract][Full Text] [Related]
55. Preexisting conditions in pediatric ALL patients: Spectrum, frequency and clinical impact.
Schütte P; Möricke A; Zimmermann M; Bleckmann K; Reismüller B; Attarbaschi A; Mann G; Bodmer N; Niggli F; Schrappe M; Stanulla M; Kratz CP
Eur J Med Genet; 2016 Mar; 59(3):143-51. PubMed ID: 26732628
[TBL] [Abstract][Full Text] [Related]
56. Carrier frequency of mutation 657del5 in the NBS1 gene in a population of Polish pediatric patients with sporadic lymphoid malignancies.
Chrzanowska KH; Piekutowska-Abramczuk D; Popowska E; Gładkowska-Dura M; Małdyk J; Syczewska M; Krajewska-Walasek M; Goryluk-Kozakiewicz B; Bubała H; Gadomski A; Gaworczyk A; Kazanowska B; Kołtan A; Kuźmicz M; Luszawska-Kutrzeba T; Maciejka-Kapuścińska L; Stolarska M; Stefańska K; Sznurkowska K; Wakulińska A; Wieczorek M; Szczepański T; Kowalczyk J
Int J Cancer; 2006 Mar; 118(5):1269-74. PubMed ID: 16152606
[TBL] [Abstract][Full Text] [Related]
57. 657del5 mutation in the gene for Nijmegen breakage syndrome (NBS1) in a cohort of Russian children with lymphoid tissue malignancies and controls.
Resnick IB; Kondratenko I; Pashanov E; Maschan AA; Karachunsky A; Togoev O; Timakov A; Polyakov A; Tverskaya S; Evgrafov O; Roumiantsev AG
Am J Med Genet A; 2003 Jul; 120A(2):174-9. PubMed ID: 12833396
[TBL] [Abstract][Full Text] [Related]
58. A Modified NHL-BFM-95 Regimen Produces Better Outcome Than HyperCVAD in Adult Patients with T-Lymphoblastic Lymphoma, a Two-Institution Experience.
Li C; Wuxiao ZJ; Chen X; Chen G; Lu Y; Xia Z; Liang Y; Wang H
Cancer Res Treat; 2020 Apr; 52(2):573-585. PubMed ID: 32019289
[TBL] [Abstract][Full Text] [Related]
59. Chromosomal instability associated with adverse outcome: a case report of patient with Nijmegen breakage syndrome and rapidly developed T-NHL with complex karyotype.
Włodarczyk M; Lejman M
Mol Cytogenet; 2020; 13():35. PubMed ID: 32843899
[TBL] [Abstract][Full Text] [Related]
60. Treatment of lymphoid malignancies in patients with ataxia-telangiectasia.
Ben Arush MW
Med Pediatr Oncol; 1999 Jun; 32(6):479-80. PubMed ID: 10358719
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
